XML 87 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segments were as follows (in thousands):
 
For the Three Months Ended March 31,
 
2020
 
2019
Restricted stock / units
$
775

 
$
841

Performance shares / units
425

 
465

Non-qualified and performance stock options

 
124

Total stock-based compensation expense
$
1,200

 
$
1,430


Schedule of Unrecognized Compensation Cost, Nonvested Awards
As of March 31, 2020, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):
 
March 31, 2020
Restricted stock and restricted stock units
$
12,832

Performance shares and performance share units
13,743

Total unrecognized stock-based compensation expense
$
26,575





Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes information about stock option activity for the three months ended March 31, 2020:
 
March 31, 2020
 
Weighted Average
Exercise Price
Options outstanding at January 1, 2020
1,441,202

 
$
18.26

Canceled
(13,882
)
 
21.99

Options outstanding at March 31, 2020
1,427,320

 
$
18.22

Options exercise price range at March 31, 2020
$
12.15

to
$
33.36

Options exercisable at March 31, 2020
1,427,320

 
 
Shares available for grant at March 31, 2020*
825,893

 
 

________
 *
Shares available for grant under the 2018 Plan as of March 31, 2020 reduced by net restricted stock and restricted stock unit award activity of 936,494 shares and performance share and performance share unit award activity of 1,859,054 shares
Schedule of Share-based Compensation, Stock Options Outstanding

The following table summarizes information about stock options outstanding at March 31, 2020:
 
Options Outstanding
 
Options Exercisable
Exercise Prices
Number
Outstanding at
March 31, 2020
 
Weighted Average
Remaining
Contractual Life (Years)
 
Weighted Average
Exercise Price
 
Number
Exercisable at
March 31, 2020
 
Weighted Average
Exercise Price
$ 12.15 – $20.00
786,884

 
5.5
 
$
12.75

 
786,884

 
$
12.75

$ 20.01 – $25.00
305,249

 
1.4
 
24.45

 
305,249

 
24.45

$ 25.01 – $30.00
330,691

 
0.4
 
25.28

 
330,691

 
25.28

$ 30.01 – $33.36
4,496

 
1.1
 
33.36

 
4,496

 
33.36

Total
1,427,320

 
3.5
 
$
18.22

 
1,427,320

 
$
18.22


Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):
 
March 31, 2020
 
Weighted Average Fair Value
Stock / Units unvested at
January 1, 2020
965,085

 
$
11.32

Granted
764,012

 
7.11

Canceled
(23,424
)
 
11.78

Stock / Units unvested at
March 31, 2020
1,705,673

 
$
9.43


Share-based Compensation, Performance Shares Award Unvested Activity

The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):
 
March 31, 2020
 
Weighted Average Fair Value
Shares / Units unvested at January 1, 2020
753,272

 
$
11.82

Granted
523,329

 
7.08

Canceled
(17,327
)
 
11.98

Shares / Units unvested at
March 31, 2020
1,259,274

 
$
9.85